Clinical Trials

ADHD Research Study

What is the purpose of this study?

University of Cincinnati (UC) and Cincinnati Children’s Hospital Medical Center (CCHMC) are conducting a research study to better understand the how the brain works in children with Attention Deficit Hyperactivity Disorder (ADHD). We are also interested in understanding how an ADHD medication called atomoxetine can make the ADHD symptoms in a child better and whether we can predict in advance how well this medicine will work.

Who can participate?

Children 7-12 years old who 

  • have been diagnosed with ADHD. 
  • have either never received medicines to treat ADHD or have not received medicines that work well without side effects

Conditions

  • ADD/ADHD
  • Disabilities: Intellectual
  • Medications
  • Neurology

What is involved?

The study lasts 6 weeks and includes 7 outpatient study visits. The following is a list of procedures that will take place during the study:

  • Informed Consent 
  • Initial visit and screening questionnaire
  • Brief cognitive testing 
  • Blood draw 
  • Brief ECG 
  • Behavior rating scales 
  • Administration of study medication or placebo 
  • A procedure called Transcranial Magnetic Stimulation (TMS) to assess brain activity

What are the benefits?

Your participation will aid in the understanding and development of future research in children with ADHD. You may also benefit from learning more about your child’s behavior and ADHD symptoms. The medication may help to decrease your child’s ADHD symptoms.

Will I get all the facts about the study?

Parents interested in having their child participate may contact us for more information. We will provide a consent form that thoroughly explains all of the details of the study, and we are available to answer questions. The form covers all of the procedures, the risks, the benefits, reimbursement, and whom to contact with questions or concerns. A member of the study staff will review the consent form with you and will be sure that all of your questions are answered. Study procedures will not begin until a parent or guardian has signed this form and, the child has also given verbal agreement.

What are the risks and discomforts of the study?

There are minimal risks associated with participating in this study. Such risks include side effects from taking atomoxetine as well as those associated with the TMS procedure.

Do participants receive pay, compensation or reimbursement?

Your child will be reimbursed, at the end of each visit, $15 cash for travel related expenses for each Visit 1-6 up to $90. Your child will not be reimbursed for the screening visit. Your child will only be reimbursed for the visits your child completes.

Who should I contact for more information?

Adam Sarvis
Research Assistant
(513) 558-3161
Department of Psychiatry and Behavioral Neuroscience
University of Cincinnati
260 Stetson Street, Suite 3200
Cincinnati, OH 45212
adam.sarvis@uc.edu

Date

Ongoing